
Herbion (Herbion Naturals) is owned by Herbion Pakistan Private Limited, a privately held pharmaceutical and natural healthcare company headquartered in Karachi, Pakistan. Founded in 1983, it sells more than 250 products, led by Linkus cough syrup, across pharmaceuticals, nutraceuticals, and personal care, exporting to over 40 countries on five continents with manufacturing partnerships including Reckitt and Abbott.
Parent Company
Founded
1983
Status
Private
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Herbion | Herbion Pakistan Private Limited | Wholly owned |
Herbion was founded in 1983 in Pakistan, at a time when the country's pharmaceutical sector was dominated by multinational subsidiaries and herbal medicine remained an informal, largely unbranded market. The founders' premise was to apply pharmaceutical manufacturing discipline to natural and herbal products, producing standardized herbal formulations to regulated quality standards.
The breakthrough product was Linkus Cough Syrup, an herbal expectorant that became the company's export engine. Herbion's international journey began with Linkus shipments to Central Asian markets, where it gained recognition in countries such as Kazakhstan and Uzbekistan, then expanded into neighboring regions and eventually across five continents.
Through the 1990s and 2000s the product line widened from respiratory care into digestive care, CNS care, child care, nutritional products, personal care, and allopathic generics, growing past 250 products in total. Regulatory expansion followed: the company's facilities earned GMP certifications from PIC/S, Canada, Russia, Ukraine, Belarus, and Pakistan, and many of its products are registered with the US FDA, enabling the Herbion Naturals branded presence in the American natural products market.
Two contract manufacturing milestones underscored its quality credentials. Since 2015, Herbion has manufactured products for Abbott Labs Pakistan, including the Cofloz respiratory care line that became a household name. In 2018, Reckitt selected Herbion to manufacture Strepsils in Pakistan after its global safety and leadership team audited the facility; commercial production began October 9, 2018.
As of 2026, Herbion reports operations in more than 40 countries and a workforce exceeding 2,000, maintaining headquarters and manufacturing in Karachi with offices in markets including Armenia, Belarus, Canada, and Kyrgyzstan.
What is Herbion Pakistan?
A privately held pharmaceutical and natural healthcare manufacturer founded in 1983 and headquartered in Karachi, producing 250-plus herbal, nutraceutical, personal care, and generic products for 40-plus export markets.
Who owns Herbion?
Private Pakistani shareholders own the company; it has no foreign parent or public listing. Nadeem Khalid serves as CEO.
Does Herbion manufacture for other companies?
Yes. It has manufactured Strepsils for Reckitt in Pakistan since October 2018 and respiratory products for Abbott Labs Pakistan since 2015, plus private label work.
Where are Herbion products made?
At its facilities in Karachi's Landhi Industrial Area and Islamabad, Pakistan.
Is Herbion certified?
Yes. Its facilities hold GMP certifications from PIC/S, Health Canada, Russia, Ukraine, Belarus, and Pakistan, and many products carry US FDA registrations.
How many employees does Herbion have?
The company reports more than 2,000 employees across manufacturing, R&D, marketing, and international offices.
No major recalls, FDA warning letters, or regulatory actions involving Herbion products are documented as of November 2026. The company markets under GMP certifications across multiple jurisdictions and FDA product registrations in the US. As with all supplement and herbal manufacturers, its products carry standard regulatory obligations in each market, and no violation or enforcement history appears in public record.
No direct competitors found in the same category. This could be because Herbionoperates in a unique market segment or we're still building our competitor database.
Looking for brands with different ownership structures? These similar brands are not owned by Herbion Pakistan Private Limited, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by ADARx Pharmaceuticals, Inc.
Biotechnology brand of ADARx Pharmaceuticals, the San Diego siRNA company that listed on Nasdaq in September 2026.
ADARx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Adcock Ingram Holdings Limited
South African pharmaceutical brand behind Panado and Myprodol, now privately held by Bidvest and NATCO Pharma.
Adcock Ingram operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Alfa-Pharm CJSC
Armenia's largest pharmaceutical distributor and pharmacy chain, importing medicines from more than 70 global manufacturers since 1996.
Alfa-Pharm operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Amgen Inc.
Master biotechnology brand of Amgen Inc., the world's largest independent biotech, covering its full portfolio of biologic medicines.
Amgen operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by AstraZeneca PLC
British-Swedish pharmaceutical brand behind Tagrisso and Farxiga, owned by publicly traded AstraZeneca PLC formed by merger in 1999.
AstraZeneca operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Biogen Inc.
The biotechnology brand of Biogen Inc., focused on neurology therapeutics.
Biogen operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.